Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared on LinkedIn:
“From Guidelines to Real-World Clinical Practice.
I’m proud to be invited to take part in this expert meeting, where we will move beyond guidelines and focus on one of the most important questions in oncology:
How do we translate evidence and guidelines into practical, individualized decisions for our patients with metastatic hormone-sensitive prostate cancer (mHSPC)?
Looking forward to an engaging, evidence-based discussion with leading experts on how we can bridge the gap between evidence and everyday practice and ultimately deliver the right treatment to the right patient at the right time.”
Rasha Aboelhassan was recognized among OncoDaily’s 100 Influential Women in Oncology, highlighting her contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15.
